MTX withdrawal after COVID-19 vaccination improves immunogenicity in RA patients but at a cost

Brazil: Data from a recent study revealed that 2-week methotrexate (MTX) discontinuation after each dose of the Sinovac-CoronaVac vaccine improves anti-SARS-CoV-2 immunogenicity in patients with...

Related Keywords

Sao Paulo ,Sãpaulo ,Brazil ,Eloisa Bonfa ,Paulo Faculdade ,Rheumatology Division ,Clinical Disease Activity Index ,Disease Activity Score ,Rheumatic Diseases Published Online First ,Rheumatoid Arthritis ,Sars Cov 2 Vaccine ,Immunogenicity ,Methotrexate ,Discontinuation ,Sinovac Coronavac Vaccine ,